Publication date: September 2025 Source: Best Practice & Research Clinical Haematology, Volume 38, Issue 3 Author(s): Diana Cirstea, Benjamin Puliafito, Bridget E. Kim, Matt Lei, Noopur Raje
Bispecific T-cell engager therapy for multiple myeloma. // Best Practice & Research Clinical Haematology. – URL: https://www.sciencedirect.com/science/article/pii/S1521692625000556?dgcid=rss_sd_all
Bispecific T-cell engager therapy for multiple myeloma. Best Practice & Research Clinical Haematology. https://www.sciencedirect.com/science/article/pii/S1521692625000556?dgcid=rss_sd_all
“Bispecific T-cell engager therapy for multiple myeloma.” Best Practice & Research Clinical Haematology.
@article{article37318,
title = {Bispecific T-cell engager therapy for multiple myeloma},
journal = {Best Practice \& Research Clinical Haematology},
url = {https://www.sciencedirect.com/science/article/pii/S1521692625000556?dgcid=rss_sd_all}
}
Nature Reviews Cancer, Published online: 19 November 2026; doi:10.1038/s41568-026-01001-2 In this Journal Club, Chien-Han Kao and Ruey-Hwa Chen discuss a study showing that tumours use both de novo purine biosynthesis and purine salvage...
npj Precision Oncology, Published online: 19 November 2026; doi:10.1038/s41698-026-01779-2 Targeting SMYD3 in cancer-associated fibroblasts relieves immune suppression and improves anti-PD-L1 response in HPV-negative HNSCC
npj Precision Oncology, Published online: 19 November 2026; doi:10.1038/s41698-026-01786-3 Postoperative timing effects on AI-based resection-cavity segmentation in glioma: multi-site evaluation and relevance assessment